AD

Amol Dattatrya Nikam

Director Director DIN 07826093
DIN 07826093 First appointment May 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2017
Shareholding value Locked Premium profile

About Amol Dattatrya Nikam

Amol Dattatrya Nikam has 9 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

DIN 07826093
Primary Designation Director
First Appointment 18 May 2017
Oldest Company Age 12 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Copioous Biotech Private Limited U01403PN2014PTC152080
Director 18 May 2017 2014 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Copioous Biotech Private Limited
Premium access

Shareholding and investment profile for Amol Dattatrya Nikam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Dattatrya Nikam

Amol Dattatrya Nikam has 9 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in Technology. Contributes to corporate operations.

Amol Dattatrya Nikam is associated with 0 companies as Director.

Amol Dattatrya Nikam has expertise in Technology.

Amol Dattatrya Nikam has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available